WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter

(TSX:WELL) (OTCQX:WHTCF) (TSX:AIDX) WELL Health Technologies Corp. and (TSX:AIDX) HEALWELL AI Inc. announced that the Commissioner of Competition has concluded the Competition Bureau's review of WELL's acquisition of a majority interest in HEALWELL and has issued a No Action Letter. The No Action Letter was issued on October 22, 2026, confirming that the Commissioner does not, at this time, intend to make an application under section 92 of the Competition Act regarding WELL's acquisition of a controlling interest in HEALWELL, which was completed on April 1, 2025. The Transaction also included HEALWELL's concurrent acquisition of Orion Health. In December 2025, the Competition Bureau announced that it had obtained a Federal Court order for the production of records and information relating to the Transaction. WELL and HEALWELL cooperated with the Bureau throughout its review and produced the requested records and information. Hamed Shahbazi, Founder, Chairman, and CEO of WELL, stated that the company is pleased with the conclusion of the review and the issuance of the No Action Letter, and that WELL remains focused on executing its strategy and delivering value to healthcare practitioners, patients, and shareholders. WELL Health Technologies Corp. is described as Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL owns and operates 275 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms, and IT management services. WELL also provides cybersecurity services through its CYBERWELL subsidiary. HEALWELL AI is described as a healthcare artificial intelligence company focused on preventative care, developing and acquiring technology and clinical science capabilities, including data science, AI-powered patient identification, and clinical decision support.

WELL Health Redeems $70 Million 5.50% Convertible Debentures

(TSX:WELL) (OTCQX:WHTCF) WELL Health Technologies Corp. redeemed early all of its outstanding 5.50% convertible senior unsecured debentures on August 19, 2026. The Debentures were due December 31, 2026 and had an aggregate principal amount of $70,000,000. On the Redemption Date, WELL paid holders a redemption price equal to $1,007.3333 per $1,000 principal amount of Debentures, in cash, representing $1,000 principal and $7.3333 for accrued and unpaid interest. WELL used cash on hand to pay the redemption price. The Debentures ceased trading at the opening of trading on the Redemption Date and were delisted at the close of trading on the Redemption Date. The successful closing of WELL's inaugural $150 million senior unsecured notes offering in July gave the company the capital to retire these debentures ahead of maturity. WELL owns and operates 275 clinics in Canada, supporting more than 5 million annual patient visits.

WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing

(TSX: WELL) WELL Health Technologies Corp. announced that its subsidiary, WELLSTAR Technologies Corp., has closed a financing transaction for aggregate gross proceeds of C$50 million, consisting of C$36.2 million from a treasury offering of subscription receipts and C$13.8 million from a secondary offering. The financing was anchored by a large Canadian bank-owned asset manager and included new institutional investors, as well as continued support from existing shareholders, including WELL and certain members of WELL and WELLSTAR management, board of directors, and employees. Including the Treasury Offering, WELLSTAR financings have raised an aggregate of C$162 million in the last 19 months, with C$148 million representing treasury proceeds to WELLSTAR, including a C$62 million financing completed in December 2025 and a C$50 million financing completed in December 2024. WELLSTAR provides a comprehensive, holistic solution for healthcare providers across Canada, with over 40% of practitioners currently using its products and services. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. The company projects that WELLSTAR's trading debut on the TSXV is expected in September, and the Transaction and intended listing of WELLSTAR's subordinate voting shares on the TSX Venture Exchange is expected to close on or about September 16, 2026.

Welltower Reports Second Quarter 2026 Results

(NYSE: WELL) Welltower Inc. announced results for the quarter ended June 30, 2026, reporting net income attributable to common stockholders of $0.61 per diluted share. The company reported quarterly normalized funds from operations attributable to common stockholders of $1.60 per diluted share, an increase of 25.0% over the prior year. Year-to-date, Welltower closed or is under contract to close $15.5 billion of pro rata gross investments, including $9.4 billion completed in the six months ended June 30, 2026, and $6.1 billion closed or under contract to close subsequent to quarter end, excluding development funding. The company completed $843 million of pro rata dispositions and loan repayments during the second quarter, including $561 million of Outpatient Medical dispositions and $155 million of loan repayments. As of June 30, 2026, Welltower reported Net Debt to Adjusted EBITDA of 2.99x and approximately $9.5 billion of available liquidity. In July 2026, the company issued C$1.15 billion of senior unsecured notes with a weighted-average coupon of 3.95%. The Board of Directors announced a 15% increase in the quarterly dividend to $0.85 per share.

WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering

(TSX: WELL) (OTCQX: WHTCF) WELL Health Technologies Corp. announced it has closed its previously announced inaugural private placement offering of $150 million aggregate principal amount of 6.875% senior unsecured notes due July 15, 2031. The Notes were issued at par under a trust indenture and are direct senior unsecured obligations of WELL, ranking equally in right of payment with all other present and future senior unsecured indebtedness of the Company. The Company intends to use the net proceeds to fully repay its convertible debentures maturing December 2026 and for general corporate purposes. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. BMO Capital Markets acted as lead bookrunner for the Offering, with RBC Capital Markets, Stifel, J.P. Morgan and TD Securities acting as joint bookrunners, Scotiabank as co-lead manager, and CIBC Capital Markets and ATB Cormark Capital Markets as co-managers. The Notes were offered in each of the provinces of Canada on a private placement basis and have not been and will not be registered under the U.S. Securities Act of 1933. The company projects to retire its December 2026 convertible debentures and move forward with a cleaner, more flexible balance sheet.

Welltower Board of Directors Approves 15% Increase in Quarterly Dividend to $0.85 per Share

(NYSE:WELL) Welltower Inc. announced that it expects to raise its quarterly common stock dividend to $0.85 per share, beginning with the second quarter of 2026. The Board has approved a further mid-teens percentage increase to the dividend, following low double-digit increases in each of the past two years. The company completed approximately $11 billion of net investment activity in 2025 and $10.5 billion of closed or announced investment activity through the first four months of 2026. Welltower's portfolio consists of 2,500+ seniors and wellness housing communities across the United States, United Kingdom, and Canada. The company reports strong cash flow per share growth in recent years and maintains extraordinarily low balance sheet leverage metrics. The company projects that strong secular tailwinds and the digital transformation of its portfolio are expected to propel business growth, with unlevered returns on acquisitions expected to be comparable to or slightly higher than prior years.

WELL Health Announces Approval of Normal Course Issuer Bid

WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) announced that its Notice of Intention to Make a Normal Course Issuer Bid (NCIB) has been approved by the Toronto Stock Exchange (TSX). The company has also entered into an automatic share purchase plan (ASPP) with a broker to facilitate repurchases of its common shares. Under the NCIB, WELL may acquire up to 12,770,172 shares over the next 12 months, representing approximately 5.0% of its issued and outstanding shares. As of May 7, 2026, the company had 255,408,705 shares issued and outstanding. Daily purchases on the TSX will not exceed 383,933 shares, which is 25% of the average daily trading volume over the preceding six months of 1,535,732 shares. The NCIB will be effective from May 21, 2026 to May 20, 2027, and all shares purchased will be returned to treasury for cancellation. The company previously purchased 654,100 shares at a weighted average price of $4.31 per share under the 2025 NCIB.

Welltower Issues Business Update

Welltower Inc. (NYSE: WELL) released a business update on April 28, 2026, highlighting its focus on rental housing for aging seniors across the United States, United Kingdom, and Canada. The company manages a portfolio of over 2,500 seniors and wellness housing communities, emphasizing its position at the intersection of housing and hospitality. Welltower describes itself as an operating company within a real estate wrapper, driven by partnerships and a data science platform. The update reiterates the company's aspiration to deliver long-term compounding of per share growth for investors.

Welltower Reports First Quarter 2026 Results

Welltower Inc. (NYSE: WELL) announced its results for the quarter ended March 31, 2026, reporting net income attributable to common stockholders of $1.02 per diluted share and normalized funds from operations (FFO) of $1.47 per diluted share, a 23% increase over the prior year. The company achieved total portfolio same store NOI growth of 16.4%, driven by 22.1% growth in its Seniors Housing Operating portfolio. Year-to-date, Welltower closed or is under contract to close $10.5 billion of investment activity and completed $2.8 billion of pro rata dispositions and loan repayments in the first quarter. The company completed the acquisition of a Canadian portfolio of 38 seniors housing communities for C$4.1 billion and declared a quarterly cash dividend of $0.74 per share. Guidance for 2026 was revised upward, with net income guidance now at $3.24 to $3.38 per diluted share and normalized FFO guidance at $6.21 to $6.35 per diluted share.